Oramed Pharmaceuticals Inc.
US ˙ NasdaqCM ˙ US68403P2039

SecurityORMP / Oramed Pharmaceuticals Inc.
InstitutionSimplex Trading, Llc
Latest Disclosed Ownership374 shares
Latest Disclosed Value $ 1,271
Simplex Trading, Llc ownership in ORMP / Oramed Pharmaceuticals Inc.

On May 14, 2026 - Simplex Trading, Llc filed a 13F-HR form disclosing ownership of 374 shares of Oramed Pharmaceuticals Inc. (US:ORMP) valued at $1,272 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 1,145 shares of Oramed Pharmaceuticals Inc.. This represents a change in shares of -67.34% during the quarter. The current value of the position is $1,365 USD.

Simplex Trading, Llc has a history of taking positions in derivatives of the underlying security (ORMP) in the form of stock options. The firm currently holds call options representing 100 of underlying shares valued at $340 USD and put options representing 100 of underlying shares valued at $340 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ORMP / Oramed Pharmaceuticals Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ORAMED PHARMACEUTICALS COM 68403P203 374 -771 -67.34 1 -66.67 0.0000
2026-02-11 2025-12-31 13F ORAMED PHARMACEUTICALS COM 68403P203 1,145 1,145 3 0.0000
2025-08-05 2025-06-30 13F ORAMED PHARMACEUTICALS COM 68403P203 0 -7,244 -100.00 0 0.0000
2025-05-12 2025-03-31 13F ORAMED PHARMACEUTICALS COM 68403P203 7,244 3,387 87.81 0 0.0000
2025-02-11 2024-12-31 13F ORAMED PHARMACEUTICALS COM 68403P203 3,857 3,857 0 0.0000
2024-11-08 2024-09-30 13F ORAMED PHARMACEUTICALS COM 68403P203 0 -75 -100.00 0 0.0000
2024-07-25 2024-06-30 13F ORAMED PHARMACEUTICALS COM 68403P203 75 75 0 0.0000
2024-02-02 2023-12-31 13F ORAMED PHARMACEUTICALS COM 68403P203 0 -2,496 -100.00 0 0.0000
2023-11-01 2023-09-30 13F ORAMED PHARMACEUTICALS COM 68403P203 2,496 -3,600 -59.06 0 0.0000
2023-08-04 2023-06-30 13F ORAMED PHARMACEUTICALS COM 68403P203 6,096 6,096 0 0.0000
2023-04-27 2023-03-31 13F ORAMED PHARMACEUTICALS COM 68403P203 0 -38,427 -100.00 0 0.0000
2023-02-02 2022-12-31 13F ORAMED PHARMACEUTICALS COM 68403P203 38,427 -4,791 -11.09 0 -100.00 0.0005
2022-11-04 2022-09-30 13F ORAMED PHARMACEUTICALS COM 68403P203 43,218 22,855 112.24 280 201.08 0.0003
2022-08-03 2022-06-30 13F ORAMED PHARMACEUTICALS COM 68403P203 20,363 20,363 93 0.0001
2022-05-02 2022-03-31 13F ORAMED PHARMACEUTICALS COM 68403P203 0 -6,930 -100.00 0 -100.00
2022-02-23 2021-12-31 13F/A-1 ORAMED PHARMACEUTICALS COM 68403P203 6,930 6,930 98 0.0001
2021-02-02 2020-12-31 13F ORAMED PHARMACEUTICALS COM 68403P203 0 -24,124 -100.00 0 -100.00
2020-10-14 2020-09-30 13F ORAMED PHARMACEUTICALS COM 68403P203 24,124 24,124 62 0.0001
2020-04-28 2020-03-31 13F ORAMED PHARM COM 68403P203 0 -6,104 -100.00 0 -100.00
2020-02-05 2019-12-31 13F ORAMED PHARM COM 68403P203 6,104 6,104 31 0.0001
2019-10-15 2019-09-30 13F ORAMED PHARM COM 68403P203 0 -1,775 -100.00 0 -100.00
2019-07-26 2019-06-30 13F ORAMED PHARM COM 68403P203 1,775 1,775 6 0.0000
2019-04-18 2019-03-31 13F ORAMED PHARM COM 68403P203 0 -1,035 -100.00 0 -100.00
2019-01-16 2018-12-31 13F ORAMED PHARM COM 68403P203 1,035 488 89.21 3 50.00 0.0000
2018-10-23 2018-09-30 13F ORAMED PHARM COM 68403P203 547 547 -47.15 2 -33.33 0.0000
2017-01-11 2016-12-31 13F ORAMED PHARM COM 68403P203 0 -2,673 -100.00 0 -100.00
2016-10-07 2016-09-30 13F ORAMED PHARM COM 68403P203 2,673 -1,500 -35.95 19 -44.12 0.0013
2016-07-18 2016-06-30 13F ORAMED PHARM COM 68403P203 4,173 3,421 454.92 34 580.00 0.0023
2016-04-14 2016-03-31 13F ORAMED PHARM COM 68403P203 752 -2,425 -76.33 5 -81.48 0.0004
2016-01-20 2015-12-31 13F ORAMED PHARM COM 68403P203 3,177 3,177 322.47 27 440.00 0.0021
2015-04-21 2015-03-31 13F ORAMED PHARM COM 68403P203 0 -175 -100.00 0 -100.00
2015-03-04 2014-12-31 13F ORAMED PHARM COM 68403P203 175 175 1 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F ORAMED PHARMACEUTICALS CALL Call 100 0.00 0 n/a n/a n/a
2026-02-11 2025-12-31 13F ORAMED PHARMACEUTICALS CALL Call 100 -94.74 0 n/a n/a n/a
2025-11-12 2025-09-30 13F ORAMED PHARMACEUTICALS CALL Call 1,900 0.00 0 n/a n/a n/a
2025-08-05 2025-06-30 13F ORAMED PHARMACEUTICALS CALL Call 1,900 137.50 0 n/a n/a n/a
2025-05-12 2025-03-31 13F ORAMED PHARMACEUTICALS CALL Call 800 0 n/a n/a n/a
2024-11-08 2024-09-30 13F ORAMED PHARMACEUTICALS CALL Call 0 -100.00 0 n/a n/a n/a
2024-07-25 2024-06-30 13F ORAMED PHARMACEUTICALS CALL Call 5,300 1.92 0 n/a n/a n/a
2024-04-25 2024-03-31 13F ORAMED PHARMACEUTICALS CALL Call 5,200 -60.00 0 n/a n/a n/a
2024-02-02 2023-12-31 13F ORAMED PHARMACEUTICALS CALL Call 13,000 6.56 0 n/a n/a n/a
2023-11-01 2023-09-30 13F ORAMED PHARMACEUTICALS CALL Call 12,200 -12.86 0 n/a n/a n/a
2023-08-04 2023-06-30 13F ORAMED PHARMACEUTICALS CALL Call 14,000 38.61 0 n/a n/a n/a
2023-04-27 2023-03-31 13F ORAMED PHARMACEUTICALS CALL Call 10,100 -51.44 0 n/a n/a n/a
2023-02-02 2022-12-31 13F ORAMED PHARMACEUTICALS CALL Call 20,800 -30.90 0 -100.00 n/a n/a n/a
2022-11-04 2022-09-30 13F ORAMED PHARMACEUTICALS CALL Call 30,100 81.33 195 156.58 n/a n/a n/a
2022-08-03 2022-06-30 13F ORAMED PHARMACEUTICALS CALL Call 16,600 -22.43 76 -58.92 n/a n/a n/a
2022-05-02 2022-03-31 13F ORAMED PHARMACEUTICALS CALL Call 21,400 38.96 185 -15.53 n/a n/a n/a
2022-02-23 2021-12-31 13F/A ORAMED PHARMACEUTICALS CALL Call 15,400 23.20 219 31.93 n/a n/a n/a
2022-02-04 2021-12-31 13F ORAMED PHARMACEUTICALS CALL Call 12,500 166 n/a n/a n/a
2021-10-28 2021-09-30 13F ORAMED PHARMACEUTICALS CALL Call 12,500 -3.10 166 -3.49 n/a n/a n/a
2021-08-12 2021-06-30 13F ORAMED PHARMACEUTICALS CALL Call 12,900 2,818.55 172 n/a n/a n/a
2021-04-26 2021-03-31 13F ORAMED PHARMACEUTICALS CALL Call 442 -4.74 0 -100.00 n/a n/a n/a
2021-02-02 2020-12-31 13F ORAMED PHARMACEUTICALS CALL Call 464 1,833.33 196 3,166.67 n/a n/a n/a
2020-10-14 2020-09-30 13F ORAMED PHARMACEUTICALS CALL Call 24 -93.33 6 -95.28 n/a n/a n/a
2020-07-13 2020-06-30 13F ORAMED PHARM CALL Call 360 -15.69 127 -1.55 n/a n/a n/a
2020-04-29 2020-03-31 13F ORAMED PHARM CALL Call 427 3.14 129 -39.44 n/a n/a n/a
2020-02-05 2019-12-31 13F ORAMED PHARM CALL Call 414 13,700.00 213 65.12 n/a n/a n/a
2019-10-15 2019-09-30 13F ORAMED PHARM CALL Call 3 -91.89 0 -100.00 n/a n/a n/a
2019-07-26 2019-06-30 13F ORAMED PHARM CALL Call 37 1,133.33 13 n/a n/a n/a
2019-04-18 2019-03-31 13F ORAMED PHARM CALL Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-01-16 2018-12-31 13F ORAMED PHARM CALL Call 10 0.00 3 -25.00 n/a n/a n/a
2018-10-23 2018-09-30 13F ORAMED PHARM CALL Call 10 -58.33 4 -76.47 n/a n/a n/a
2018-07-30 2018-06-30 13F ORAMED PHARM CALL Call 24 60.00 17 1,600.00 n/a n/a n/a
2018-04-26 2018-03-31 13F ORAMED PHARM CALL Call 15 -66.67 1 -75.00 n/a n/a n/a
2018-01-10 2017-12-31 13F ORAMED PHARM CALL Call 45 2.27 4 -55.56 n/a n/a n/a
2017-10-25 2017-09-30 13F ORAMED PHARM CALL Call 44 51.72 9 125.00 n/a n/a n/a
2017-07-12 2017-06-30 13F ORAMED PHARM CALL Call 29 190.00 4 33.33 n/a n/a n/a
2017-04-21 2017-03-31 13F ORAMED PHARM CALL Call 10 -65.52 3 -25.00 n/a n/a n/a
2017-01-11 2016-12-31 13F ORAMED PHARM CALL Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-10-07 2016-09-30 13F ORAMED PHARM CALL Call 58 0.00 1 -75.00 n/a n/a n/a
2016-07-18 2016-06-30 13F ORAMED PHARM CALL Call 58 0.00 4 300.00 n/a n/a n/a
2016-04-14 2016-03-31 13F ORAMED PHARM CALL Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-01-20 2015-12-31 13F ORAMED PHARM CALL Call 12 2 n/a n/a n/a
2015-10-08 2015-09-30 13F ORAMED PHARM CALL Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-07-08 2015-06-30 13F ORAMED PHARM CALL Call 2 -89.47 0 -100.00 n/a n/a n/a
2015-04-21 2015-03-31 13F ORAMED PHARM CALL Call 19 1 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F ORAMED PHARMACEUTICALS PUT Put 100 0 n/a n/a n/a
2025-08-05 2025-06-30 13F ORAMED PHARMACEUTICALS PUT Put 0 -100.00 0 n/a n/a n/a
2025-05-12 2025-03-31 13F ORAMED PHARMACEUTICALS PUT Put 800 -46.67 0 n/a n/a n/a
2025-02-11 2024-12-31 13F ORAMED PHARMACEUTICALS PUT Put 1,500 1,400.00 0 n/a n/a n/a
2024-11-08 2024-09-30 13F ORAMED PHARMACEUTICALS PUT Put 100 -97.56 0 n/a n/a n/a
2024-07-25 2024-06-30 13F ORAMED PHARMACEUTICALS PUT Put 4,100 192.86 0 n/a n/a n/a
2024-04-25 2024-03-31 13F ORAMED PHARMACEUTICALS PUT Put 1,400 1,300.00 0 n/a n/a n/a
2024-02-02 2023-12-31 13F ORAMED PHARMACEUTICALS PUT Put 100 -96.43 0 n/a n/a n/a
2023-11-01 2023-09-30 13F ORAMED PHARMACEUTICALS PUT Put 2,800 -9.68 0 n/a n/a n/a
2023-08-04 2023-06-30 13F ORAMED PHARMACEUTICALS PUT Put 3,100 -39.22 0 n/a n/a n/a
2023-04-27 2023-03-31 13F ORAMED PHARMACEUTICALS PUT Put 5,100 -34.62 0 n/a n/a n/a
2023-02-02 2022-12-31 13F ORAMED PHARMACEUTICALS PUT Put 7,800 65.96 0 -100.00 n/a n/a n/a
2022-11-04 2022-09-30 13F ORAMED PHARMACEUTICALS PUT Put 4,700 840.00 30 1,400.00 n/a n/a n/a
2022-08-03 2022-06-30 13F ORAMED PHARMACEUTICALS PUT Put 500 -91.94 2 -96.23 n/a n/a n/a
2022-05-02 2022-03-31 13F ORAMED PHARMACEUTICALS PUT Put 6,200 -34.74 53 -60.74 n/a n/a n/a
2022-02-23 2021-12-31 13F/A ORAMED PHARMACEUTICALS PUT Put 9,500 -3.06 135 3.85 n/a n/a n/a
2022-02-04 2021-12-31 13F ORAMED PHARMACEUTICALS PUT Put 9,800 130 n/a n/a n/a
2021-10-28 2021-09-30 13F ORAMED PHARMACEUTICALS PUT Put 9,800 0.00 130 -0.76 n/a n/a n/a
2021-08-12 2021-06-30 13F ORAMED PHARMACEUTICALS PUT Put 9,800 8,421.74 131 n/a n/a n/a
2021-04-26 2021-03-31 13F ORAMED PHARMACEUTICALS PUT Put 115 2,775.00 0 -100.00 n/a n/a n/a
2021-02-02 2020-12-31 13F ORAMED PHARMACEUTICALS PUT Put 4 -96.52 1 n/a n/a n/a
2020-04-28 2020-03-31 13F ORAMED PHARM PUT Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-05 2019-12-31 13F ORAMED PHARM PUT Put 324 1,805.88 166 3,220.00 n/a n/a n/a
2019-10-15 2019-09-30 13F ORAMED PHARM PUT Put 17 325.00 5 400.00 n/a n/a n/a
2019-07-26 2019-06-30 13F ORAMED PHARM PUT Put 4 -76.47 1 -80.00 n/a n/a n/a
2019-04-18 2019-03-31 13F ORAMED PHARM PUT Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-01-16 2018-12-31 13F ORAMED PHARM PUT Put 10 0.00 3 -25.00 n/a n/a n/a
2018-10-23 2018-09-30 13F ORAMED PHARM PUT Put 10 4 n/a n/a n/a
2016-07-18 2016-06-30 13F ORAMED PHARM PUT Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-04-14 2016-03-31 13F ORAMED PHARM PUT Put 9 80.00 1 n/a n/a n/a
2016-01-20 2015-12-31 13F ORAMED PHARM PUT Put 5 -44.44 0 -100.00 n/a n/a n/a
2015-04-21 2015-03-31 13F ORAMED PHARM PUT Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-03-04 2014-12-31 13F ORAMED PHARM PUT Put 2 1 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.